Key Takeaways The Biden administration proposed a new policy Tuesday that would allow Medicare and Medicaid to cover ...
The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...
The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.
Biden administration's proposal to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid.
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound c ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
The good news is that HHS recognizes that vitally important anti-obesity medicines like Wegovy and Zepbound should be made available to all Americans, regardless of income. The bad news is that unless ...
The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as ...
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...